Thermo Fisher Scientific Inc. (NYSE:TMO) has been analyzed by Jim Cramer recently. When asked about this particular stock, he delivered the following insights:
“Absolutely… they faced significant challenges during COVID. I must say, while Marc Casper leads Thermo Fisher excellently, I believe Danaher outshines them. Both companies have encountered hurdles, but Danaher appears to have a stronger position at the moment. I favor DHR for potential gains; it’s a preferred pick in our circle.”
Image by Chris Liverani on Unsplash
Thermo Fisher Scientific Inc. (NYSE:TMO) is engaged in providing solutions for life sciences, analytical instruments, diagnostics, laboratory products, and biopharmaceutical services. During a phone call on the June 27 episode, Cramer remarked:
“This stock is remarkable. It’s a fantastic company. Marc Casper is doing a great job, but our Charitable Trust has invested in Danaher, and it competes just as fiercely as Thermo Fisher. I highly recommend holding off until there’s an increase in orders from China. It may sound odd, but this stock has adversely affected many investors. While it seems to be stabilizing, I don’t want to advocate for it given the current ties to China, which lean bearish for now.”
While we recognize TMO’s investment potential, we feel that certain AI stocks present better prospects and reduced downside risks. If you’re interested in an AI stock that remains undervalued and stands to gain significantly from the effects of Trump-era tariffs and the trend of onshoring, check out our complimentary report on the top short-term AI stock.
READ NEXT: 30 Stocks That Could Double in Three Years and 11 Underrated AI Stocks to Consider Now.
Disclosure: None. This article was originally posted at Insider Monkey.
